Pulmonx Corporation LUNG EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's EPS (diluted)?
- Pulmonx Corporation (LUNG) reported EPS (diluted) of -$0.33 in Q1 2026.
- How has Pulmonx Corporation's EPS (diluted) changed year-over-year?
- Pulmonx Corporation's EPS (diluted) increased by 8.3% year-over-year, from -$0.36 to -$0.33.
- What is the long-term trend for Pulmonx Corporation's EPS (diluted)?
- Over 4 years (2021 to 2025), Pulmonx Corporation's EPS (diluted) has grown at a -0.4% compound annual growth rate (CAGR), from -$1.35 to -$1.33.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.